A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and Hypercholesterolemia

PHASE3CompletedINTERVENTIONAL

Enrollment

369

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

January 31, 2006

Conditions

HYPERTENSIONHYPERCHOLESTEROLEMIA

Interventions

DRUG

valsartan + simvastatin

Trial Locations (1)

Novartis Pharmaceuticals, East Hanover